NCT01177228View on ClinicalTrials.gov

Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Ulcerative Colitis
Interventions
DRUG

Vedolizumab

Vedolizumab for intravenous infusion

DRUG

Placebo

Placebo intravenous infusion

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY